Global Psychiatric Medication Therapies Market Growth (Status and Outlook) 2025-2031

September 2025 | 94 pages | ID: GA1E02DF91BEN
LP Information

Abstracts

According to this study, the global Psychiatric Medication Therapies market size will reach US$ million by 2031.

A psychiatric medication is a licensed psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Psychiatric Medication Therapies Industry Forecast” looks at past sales and reviews total world Psychiatric Medication Therapies sales in 2024, providing a comprehensive analysis by region and market sector of projected Psychiatric Medication Therapies sales for 2025 through 2031. With Psychiatric Medication Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psychiatric Medication Therapies industry.

This Insight Report provides a comprehensive analysis of the global Psychiatric Medication Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Psychiatric Medication Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psychiatric Medication Therapies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psychiatric Medication Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psychiatric Medication Therapies.

This report presents a comprehensive overview, market shares, and growth opportunities of Psychiatric Medication Therapies market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Antidepressants
• Antipsychotics
• Anxiolytics and Hypnotics
• Mood Stabilizers
• Stimulants

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Johnson and Johnson
• Eli Lilly
• Bristol-Myers Squibb
• AstraZeneca
• Novartis
• Allergan

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Psychiatric Medication Therapies Market Size (2020-2031)
  2.1.2 Psychiatric Medication Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Psychiatric Medication Therapies by Country/Region (2020, 2024 & 2031)
2.2 Psychiatric Medication Therapies Segment by Type
  2.2.1 Antidepressants
  2.2.2 Antipsychotics
  2.2.3 Anxiolytics and Hypnotics
  2.2.4 Mood Stabilizers
  2.2.5 Stimulants
2.3 Psychiatric Medication Therapies Market Size by Type
  2.3.1 Psychiatric Medication Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Psychiatric Medication Therapies Market Size Market Share by Type (2020-2025)
2.4 Psychiatric Medication Therapies Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Psychiatric Medication Therapies Market Size by Application
  2.5.1 Psychiatric Medication Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Psychiatric Medication Therapies Market Size Market Share by Application (2020-2025)

3 PSYCHIATRIC MEDICATION THERAPIES MARKET SIZE BY PLAYER

3.1 Psychiatric Medication Therapies Market Size Market Share by Player
  3.1.1 Global Psychiatric Medication Therapies Revenue by Player (2020-2025)
  3.1.2 Global Psychiatric Medication Therapies Revenue Market Share by Player (2020-2025)
3.2 Global Psychiatric Medication Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PSYCHIATRIC MEDICATION THERAPIES BY REGION

4.1 Psychiatric Medication Therapies Market Size by Region (2020-2025)
4.2 Global Psychiatric Medication Therapies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Psychiatric Medication Therapies Market Size Growth (2020-2025)
4.4 APAC Psychiatric Medication Therapies Market Size Growth (2020-2025)
4.5 Europe Psychiatric Medication Therapies Market Size Growth (2020-2025)
4.6 Middle East & Africa Psychiatric Medication Therapies Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Psychiatric Medication Therapies Market Size by Country (2020-2025)
5.2 Americas Psychiatric Medication Therapies Market Size by Type (2020-2025)
5.3 Americas Psychiatric Medication Therapies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Psychiatric Medication Therapies Market Size by Region (2020-2025)
6.2 APAC Psychiatric Medication Therapies Market Size by Type (2020-2025)
6.3 APAC Psychiatric Medication Therapies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Psychiatric Medication Therapies Market Size by Country (2020-2025)
7.2 Europe Psychiatric Medication Therapies Market Size by Type (2020-2025)
7.3 Europe Psychiatric Medication Therapies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Psychiatric Medication Therapies by Region (2020-2025)
8.2 Middle East & Africa Psychiatric Medication Therapies Market Size by Type (2020-2025)
8.3 Middle East & Africa Psychiatric Medication Therapies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PSYCHIATRIC MEDICATION THERAPIES MARKET FORECAST

10.1 Global Psychiatric Medication Therapies Forecast by Region (2026-2031)
  10.1.1 Global Psychiatric Medication Therapies Forecast by Region (2026-2031)
  10.1.2 Americas Psychiatric Medication Therapies Forecast
  10.1.3 APAC Psychiatric Medication Therapies Forecast
  10.1.4 Europe Psychiatric Medication Therapies Forecast
  10.1.5 Middle East & Africa Psychiatric Medication Therapies Forecast
10.2 Americas Psychiatric Medication Therapies Forecast by Country (2026-2031)
  10.2.1 United States Market Psychiatric Medication Therapies Forecast
  10.2.2 Canada Market Psychiatric Medication Therapies Forecast
  10.2.3 Mexico Market Psychiatric Medication Therapies Forecast
  10.2.4 Brazil Market Psychiatric Medication Therapies Forecast
10.3 APAC Psychiatric Medication Therapies Forecast by Region (2026-2031)
  10.3.1 China Psychiatric Medication Therapies Market Forecast
  10.3.2 Japan Market Psychiatric Medication Therapies Forecast
  10.3.3 Korea Market Psychiatric Medication Therapies Forecast
  10.3.4 Southeast Asia Market Psychiatric Medication Therapies Forecast
  10.3.5 India Market Psychiatric Medication Therapies Forecast
  10.3.6 Australia Market Psychiatric Medication Therapies Forecast
10.4 Europe Psychiatric Medication Therapies Forecast by Country (2026-2031)
  10.4.1 Germany Market Psychiatric Medication Therapies Forecast
  10.4.2 France Market Psychiatric Medication Therapies Forecast
  10.4.3 UK Market Psychiatric Medication Therapies Forecast
  10.4.4 Italy Market Psychiatric Medication Therapies Forecast
  10.4.5 Russia Market Psychiatric Medication Therapies Forecast
10.5 Middle East & Africa Psychiatric Medication Therapies Forecast by Region (2026-2031)
  10.5.1 Egypt Market Psychiatric Medication Therapies Forecast
  10.5.2 South Africa Market Psychiatric Medication Therapies Forecast
  10.5.3 Israel Market Psychiatric Medication Therapies Forecast
  10.5.4 Turkey Market Psychiatric Medication Therapies Forecast
10.6 Global Psychiatric Medication Therapies Forecast by Type (2026-2031)
10.7 Global Psychiatric Medication Therapies Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Psychiatric Medication Therapies Forecast

11 KEY PLAYERS ANALYSIS

11.1 Johnson and Johnson
  11.1.1 Johnson and Johnson Company Information
  11.1.2 Johnson and Johnson Psychiatric Medication Therapies Product Offered
  11.1.3 Johnson and Johnson Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Johnson and Johnson Main Business Overview
  11.1.5 Johnson and Johnson Latest Developments
11.2 Eli Lilly
  11.2.1 Eli Lilly Company Information
  11.2.2 Eli Lilly Psychiatric Medication Therapies Product Offered
  11.2.3 Eli Lilly Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Eli Lilly Main Business Overview
  11.2.5 Eli Lilly Latest Developments
11.3 Bristol-Myers Squibb
  11.3.1 Bristol-Myers Squibb Company Information
  11.3.2 Bristol-Myers Squibb Psychiatric Medication Therapies Product Offered
  11.3.3 Bristol-Myers Squibb Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bristol-Myers Squibb Main Business Overview
  11.3.5 Bristol-Myers Squibb Latest Developments
11.4 AstraZeneca
  11.4.1 AstraZeneca Company Information
  11.4.2 AstraZeneca Psychiatric Medication Therapies Product Offered
  11.4.3 AstraZeneca Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AstraZeneca Main Business Overview
  11.4.5 AstraZeneca Latest Developments
11.5 Novartis
  11.5.1 Novartis Company Information
  11.5.2 Novartis Psychiatric Medication Therapies Product Offered
  11.5.3 Novartis Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novartis Main Business Overview
  11.5.5 Novartis Latest Developments
11.6 Allergan
  11.6.1 Allergan Company Information
  11.6.2 Allergan Psychiatric Medication Therapies Product Offered
  11.6.3 Allergan Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Allergan Main Business Overview
  11.6.5 Allergan Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Psychiatric Medication Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Psychiatric Medication Therapies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antidepressants
Table 4. Major Players of Antipsychotics
Table 5. Major Players of Anxiolytics and Hypnotics
Table 6. Major Players of Mood Stabilizers
Table 7. Major Players of Stimulants
Table 8. Psychiatric Medication Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Psychiatric Medication Therapies Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Psychiatric Medication Therapies Market Size Market Share by Type (2020-2025)
Table 11. Psychiatric Medication Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Psychiatric Medication Therapies Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Psychiatric Medication Therapies Market Size Market Share by Application (2020-2025)
Table 14. Global Psychiatric Medication Therapies Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Psychiatric Medication Therapies Revenue Market Share by Player (2020-2025)
Table 16. Psychiatric Medication Therapies Key Players Head office and Products Offered
Table 17. Psychiatric Medication Therapies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Psychiatric Medication Therapies Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Psychiatric Medication Therapies Market Size Market Share by Region (2020-2025)
Table 22. Global Psychiatric Medication Therapies Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Psychiatric Medication Therapies Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Psychiatric Medication Therapies Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Psychiatric Medication Therapies Market Size Market Share by Country (2020-2025)
Table 26. Americas Psychiatric Medication Therapies Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Psychiatric Medication Therapies Market Size Market Share by Type (2020-2025)
Table 28. Americas Psychiatric Medication Therapies Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Psychiatric Medication Therapies Market Size Market Share by Application (2020-2025)
Table 30. APAC Psychiatric Medication Therapies Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Psychiatric Medication Therapies Market Size Market Share by Region (2020-2025)
Table 32. APAC Psychiatric Medication Therapies Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Psychiatric Medication Therapies Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Psychiatric Medication Therapies Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Psychiatric Medication Therapies Market Size Market Share by Country (2020-2025)
Table 36. Europe Psychiatric Medication Therapies Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Psychiatric Medication Therapies Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Psychiatric Medication Therapies Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Psychiatric Medication Therapies Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Psychiatric Medication Therapies Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Psychiatric Medication Therapies
Table 42. Key Market Challenges & Risks of Psychiatric Medication Therapies
Table 43. Key Industry Trends of Psychiatric Medication Therapies
Table 44. Global Psychiatric Medication Therapies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Psychiatric Medication Therapies Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Psychiatric Medication Therapies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Psychiatric Medication Therapies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Johnson and Johnson Details, Company Type, Psychiatric Medication Therapies Area Served and Its Competitors
Table 49. Johnson and Johnson Psychiatric Medication Therapies Product Offered
Table 50. Johnson and Johnson Psychiatric Medication Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Johnson and Johnson Main Business
Table 52. Johnson and Johnson Latest Developments
Table 53. Eli Lilly Details, Company Type, Psychiatric Medication Therapies Area Served and Its Competitors
Table 54. Eli Lilly Psychiatric Medication Therapies Product Offered
Table 55. Eli Lilly Psychiatric Medication Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Eli Lilly Main Business
Table 57. Eli Lilly Latest Developments
Table 58. Bristol-Myers Squibb Details, Company Type, Psychiatric Medication Therapies Area Served and Its Competitors
Table 59. Bristol-Myers Squibb Psychiatric Medication Therapies Product Offered
Table 60. Bristol-Myers Squibb Psychiatric Medication Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Bristol-Myers Squibb Main Business
Table 62. Bristol-Myers Squibb Latest Developments
Table 63. AstraZeneca Details, Company Type, Psychiatric Medication Therapies Area Served and Its Competitors
Table 64. AstraZeneca Psychiatric Medication Therapies Product Offered
Table 65. AstraZeneca Psychiatric Medication Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. AstraZeneca Main Business
Table 67. AstraZeneca Latest Developments
Table 68. Novartis Details, Company Type, Psychiatric Medication Therapies Area Served and Its Competitors
Table 69. Novartis Psychiatric Medication Therapies Product Offered
Table 70. Novartis Psychiatric Medication Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Novartis Main Business
Table 72. Novartis Latest Developments
Table 73. Allergan Details, Company Type, Psychiatric Medication Therapies Area Served and Its Competitors
Table 74. Allergan Psychiatric Medication Therapies Product Offered
Table 75. Allergan Psychiatric Medication Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Allergan Main Business
Table 77. Allergan Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Psychiatric Medication Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psychiatric Medication Therapies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Psychiatric Medication Therapies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Psychiatric Medication Therapies Sales Market Share by Country/Region (2024)
Figure 8. Psychiatric Medication Therapies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Psychiatric Medication Therapies Market Size Market Share by Type in 2024
Figure 10. Psychiatric Medication Therapies in Hospitals
Figure 11. Global Psychiatric Medication Therapies Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Psychiatric Medication Therapies in Clinics
Figure 13. Global Psychiatric Medication Therapies Market: Clinics (2020-2025) & ($ millions)
Figure 14. Psychiatric Medication Therapies in Others
Figure 15. Global Psychiatric Medication Therapies Market: Others (2020-2025) & ($ millions)
Figure 16. Global Psychiatric Medication Therapies Market Size Market Share by Application in 2024
Figure 17. Global Psychiatric Medication Therapies Revenue Market Share by Player in 2024
Figure 18. Global Psychiatric Medication Therapies Market Size Market Share by Region (2020-2025)
Figure 19. Americas Psychiatric Medication Therapies Market Size 2020-2025 ($ millions)
Figure 20. APAC Psychiatric Medication Therapies Market Size 2020-2025 ($ millions)
Figure 21. Europe Psychiatric Medication Therapies Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Psychiatric Medication Therapies Market Size 2020-2025 ($ millions)
Figure 23. Americas Psychiatric Medication Therapies Value Market Share by Country in 2024
Figure 24. United States Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Psychiatric Medication Therapies Market Size Market Share by Region in 2024
Figure 29. APAC Psychiatric Medication Therapies Market Size Market Share by Type (2020-2025)
Figure 30. APAC Psychiatric Medication Therapies Market Size Market Share by Application (2020-2025)
Figure 31. China Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 35. India Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Psychiatric Medication Therapies Market Size Market Share by Country in 2024
Figure 38. Europe Psychiatric Medication Therapies Market Size Market Share by Type (2020-2025)
Figure 39. Europe Psychiatric Medication Therapies Market Size Market Share by Application (2020-2025)
Figure 40. Germany Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 41. France Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Psychiatric Medication Therapies Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Psychiatric Medication Therapies Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Psychiatric Medication Therapies Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Psychiatric Medication Therapies Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 54. APAC Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 55. Europe Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 57. United States Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 58. Canada Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 59. Mexico Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 60. Brazil Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 61. China Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 62. Japan Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 63. Korea Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 65. India Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 66. Australia Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 67. Germany Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 68. France Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 69. UK Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 70. Italy Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 71. Russia Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 72. Egypt Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 73. South Africa Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 74. Israel Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 75. Turkey Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)
Figure 76. Global Psychiatric Medication Therapies Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Psychiatric Medication Therapies Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Psychiatric Medication Therapies Market Size 2026-2031 ($ millions)